H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...


Thursday, 20 January 2022
Supplying COVID-19 pills at lower cost is only part of what poorer countries need

November 2021 marks another grim flashpoint in a stream of them: the global COVID-19 death toll surpassed five million. The rapid development of vaccines has been an extraordinary achievement in the fight against COVID-19. However, successfully vaccinating the global population, especially in low-income countries, has been hampered by several challenges – notably vaccine inequity and weak health systems.

Publication Date:
Mon, 22 Nov 2021 - 09:45
African research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation in Africa

28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and identifying new development opportunities for young and mid-career scientists in the region.


Publication Date:
Tue, 28 Sep 2021 - 16:45
Drug Discovery Course: Data driven drug discovery based on machine learning and large-scale bioactivity experiments



H3D and Ersilia OSI are excited to co-present a Drug Discovery Course by Dr Miquel Duran-Frigola entitled "Data driven drug discovery based on machine learning and large-scale bioactivity experiments". The event is this Friday 3 September, 12:00 – 13:00 SAST. 

We will discuss, how machine learning techniques originally developed for text and image analysis, have the potential to revolutionize the drug discovery field.


Event details in attached flyer here.

Join the meeting here


Publication Date:
Mon, 30 Aug 2021 - 16:45
Women’s Month 2021 Feature: In conversation with Dr Lauren Arendse


This National Women’s Month, we sat down with Dr Lauren Arendse, one of H3D’s female trailblazers, to “Spill the T” on what it’s like to be a female leader in science.


“Being a small part of a bigger shared vision to train scientists and build drug discovery capabilities in Africa, and seeing the progress unfolding, is extremely rewarding and gives meaning to what I do.”
Publication Date:
Fri, 13 Aug 2021 - 17:00